. Author manuscript; available in PMC: 2022 Feb 1.

Published in final edited form as: Circ Arrhythm Electrophysiol. 2021 Jan 5;14(2):e008517. doi: 10.1161/CIRCEP.120.008517

Table 4.

Outcome by Device Characteristics

	All Patients (n=106)	No Appropriate Shock (n=86)	Appropriate Shock (n=20)	P-Value
Device Type, n (%)
Transvenous	84 (79%)	70 (81.4)	14 (70)	0.31
Epicardial	16 (15%)	11 (12.8)	5 (25)
Subcutaneous	6 (5.7%)	5 (5.8)	1 (5)
Device Chamber Type
Transvenous Single Chamber	54 (51%)	47 (54.7)	7 (35)	0.24
Transvenous Dual Chamber	30 (28%)	23 (26.7)	7 (35)	0.24
Device Outcomes
Any appropriate Device Therapy (y/n), n (%)	20 (19%)	0 (0%)	20 (100%)	n/a
All inappropriate Device Therapy (y/n), n (%)	16 (15%)	13 (15%)	3 (15%)	0.99
Device Related Complication, n (%)*
None	84 (79%)	70 (81.4)	14 (70%)	0.36
Infection	2 (1.9%)	1 (1.2%)	1 (5%)	0.34
Lead Dislodgement	3 (2.8%)	3 (3.5%)	0 (0%)	0.99
Lead Fracture	9 (8.5%)	6 (7%)	3 (15%)	0.37
Other	14 (13%)	9 (11%)	5 (25%)	0.13

P-value for Fisher’s exact test.